Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04640532
Status:
RECRUITING
Last Update Posted:
2022-05-09
First Post:
2020-11-17
Brief Title:
KRT-232 in Combination With TL-895 for the Treatment of RR MF and KRT-232 for the Treatment of JAKi Intolerant MF
Sponsor:
Kartos Therapeutics Inc
Organization:
Kartos Therapeutics Inc
Organization Data
Organization:
Kartos Therapeutics Inc
Class:
INDUSTRY
Study ID:
KRT-232-113
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kartos Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Telios Pharma Inc | INDUSTRY |